CAS: 40216-83-9; H-Hyp-Ome.Hcl

该化合物是一种蛋白质衍生物,一种氨酸,在蛋白合成和科朗形成方面起着关键作用.这种化合物的特征是分泌环第四碳的氢氧基组,这种化合物具有独特的特性.作为一个甲基酯,它有一个与碳酸配有的甲基氧基组,这增加了其在有机溶剂中的溶解性.盐化氢形式表明它是一种盐,通常能提高水溶液的稳定性和溶解性.这种化合物经常用于生物化学研究和药物应用,特别是在与碳氢化合物合成有关的研究中,以及作为peptide合成的一个潜在建筑块.其分子结构允许各种相互作用,使其在医药化学中成为有价值的化合物.此外,它可能展示生物活动,尽管具体影响将取决于其使用的背景和所涉及的生物系统.

结构式图片

相似化合物

114676-59-4 481704-21-6 102195-79-9

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号67-56-1 甲醇 | CAS号51-35-4 L-羟脯氨酸 | CAS号75-36-5 乙酰氯 | CAS号13726-69-7 B°C-L-羟脯氨酸 | CAS号32968-78-8 反式-4-羟基-L- 脯氨酸盐酸盐 | CAS号77-76-9 2,2-二甲氧基丙烷 | CAS号364750-80-1 (2S,4R)-1-(叔丁氧羰... | CAS号487048-28-2 顺式-N-b°C-4-氰基-l... | CAS号194163-91-2 反式-N-B°C-4-氰基-L... | CAS号426844-76-0 (2S,4S)-1-B°C-2... | CAS号215918-21-1 (2S)-4,4-二氟-2-(... | CAS号191280-88-3 1-N-B°C-(2S,4S)... | CAS号179990-59-1 (4R, 2S)-4-Hydr... | CAS号88043-21-4 N-B°C-反式-4-对甲苯磺... | CAS号83548-46-3 N-B°C-L-脯氨酸-4-烯甲基酯 | CAS号31560-20-0 反-1-苯甲酰-4-羟基-L-脯氨酸甲酯

合成工艺路线路线简述

  • 合成目标产物 Trans-4-Hydroxy-L-Proline Methyl Ester Hydrochloride 主要起始原料 Methanol And Boc-Hyp-Oh
  • (文献来源)合成步骤主要原料 Methanol 和 Boc-Hyp-Oh
N-Boc-反式-4-羟基-L-脯氨酸甲酯置于盐酸体系中,用 1,4-二氧六环 作为反应溶剂,化学反应 3.0H,反应生成 反式-4-羟基-L-脯氨酸甲酯盐酸盐
参考文献:Pyrrole Compounds As Granzyme B Inhibitors
标题:Pyrrole Compounds As Granzyme B Inhibitors
摘要:吡咯化合物作为粒酶b抑制剂,包括这些化合物的组合物以及使用这些化合物的方法.提供了一种治疗皮肤硬化病,大疱性表皮松解症,放射性皮炎,斑秃和蝶形红斑狼疮的方法.

海关参考信息

专利信息


专利号:US-8829184-B2
优先权日:2010-04-15
标题:Intermediates useful for the synthesis of pyrrolobenzodiazepines
发明人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD
权利人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD; SPIROGEN SARL
摘要:A compound of formula (I): which is substantially free of any of the corresponding compound of formula (IB): methods of making such compounds, and the further transformation of such compounds.

专利号:US-2012095211-A1
优先权日:2010-09-22
标 题 :Substituted proline inhibitors of hepatitis c virus replication
发明人:BUCKMAN BRAD; NICHOLAS JOHN B; SEREBRYANY VLADIMIR; SEIWERT SCOTT D
权利人:BUCKMAN BRAD; NICHOLAS JOHN B; SEREBRYANY VLADIMIR; SEIWERT SCOTT D; INTERMUNE INC
摘要:The embodiments provide compounds of the general Formulae I, Ia, II, IIa, III, IIIa, IIIb, IV, IVa, IVb, V, Va, Vb, VI, VIa, VIb, and VIc, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. The embodiments also provide methods for the synthesis of subject compounds and intermediates in the synthetic methods.

专利号:US-2024124938-A1
优先权日:2019-10-16
标题:Visual detection of pbd induced dna crosslinks
发明人:LACHAUD CHRISTOPHE; COMBES SÉBASTIEN; ABEL SÉBASTIEN; AUDOLY GILLES; BERRADA SARA
权利人:INST NAT SANTE RECH MED; INST JEAN PAOLI & IRENE CALMETTES; AIX MARSEILLE UNIV; CENTRE NAT RECH SCIENT
摘要:The present invention relates to the field of oncology. laboratory tools and methods, and especially anti-tumor DNA crosslinking agents. Most patients with advanced solid tumors develop resistance to chemotherapy due to the ability of cancer cells to repair or tolerate sustained DNA damages. The inventors showed that the compounds according to the present invention allow the detection and visualization of alkylated DNA damages induced by PBDs without altering their DNA crosslinking ability. This enables the study of the effect and properties of PBDs. In particular, the present invention relates new derivates of PBD molecules and their synthesis. The present invention also relates to a method for visualizing DNA crosslinking: to a method for assessing the resistance of a tumor to a crosslinking agent and to a method for identifying a molecule or treatment for improving the efficiency of a crosslinking agent.

专利号:US-2013035484-A1
优先权日:2010-04-15
标 题:Intermediates useful for the synthesis of pyrrolobenzodiazepines

专利号:CN-109957566-B
优先权日:2017-12-26
标 题 :Modified oligonucleotides and compounds useful in the synthesis of modified oligonucleotides

专利号:CN-109957566-A
优先权日:2017-12-26
标 题 :Modified oligonucleotides and compounds useful in the synthesis of modified oligonucleotides
常州瀚轩生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hanxuanbio.com
企业联系电话:18602598900👤
📞常州瀚轩生物科技有限公司 ⚠️参考联系方式
联系人:左经理
电话:18602598900
手机:18602598900

邮箱:sales@hanxuanbio.com
通信地址: 江苏常州天宁区兰陵街道浦前社区
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏常州天宁区兰陵街道浦前社区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Beck A, Et Al. Strategies And Challenges For The Next Generation Of Antibody-Drug Conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.
[参考文献]: Nalawansha Da, Et Al. Protacs: An Emerging Therapeutic Modality In Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

合成参考文献


参考文献:10.1186/s40508-015-0039-0
摘要:Müller CR, Rosen A, Domínguez de María P. Multi-step enzyme-organocatalyst C–C bond forming reactions in deep-eutectic-solvents: towards improved performances by organocatalyst design. Sustainable Chemical Processes. 2015 Aug 12;3(1):12. doi: 10.1186/s40508-015-0039-0.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知